BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Teachey DT. New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr 2012;24:1-8. [PMID: 22157362 DOI: 10.1097/MOP.0b013e32834ea739] [Cited by in Crossref: 73] [Cited by in F6Publishing: 32] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Vavassori S, Galson JD, Trück J, van den Berg A, Tamminga RYJ, Magerus-Chatinet A, Pellé O, Camenisch Gross U, Marques Maggio E, Prader S, Opitz L, Nüesch U, Mauracher A, Volkmer B, Speer O, Suda L, Röthlisberger B, Zimmermann DR, Müller R, Diepstra A, Visser L, Haralambieva E, Neven B, Rieux-Laucat F, Pachlopnik Schmid J. Lymphadenopathy driven by TCR-Vγ8Vδ1 T-cell expansion in FAS-related autoimmune lymphoproliferative syndrome. Blood Adv 2017;1:1101-6. [PMID: 29296752 DOI: 10.1182/bloodadvances.2017006411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
2 Suttorp M, Classen CF. Splenomegaly in Children and Adolescents. Front Pediatr 2021;9:704635. [PMID: 34307263 DOI: 10.3389/fped.2021.704635] [Reference Citation Analysis]
3 Balomenos D, Shokri R, Daszkiewicz L, Vázquez-Mateo C, Martínez-A C. On How Fas Apoptosis-Independent Pathways Drive T Cell Hyperproliferation and Lymphadenopathy in lpr Mice. Front Immunol 2017;8:237. [PMID: 28344578 DOI: 10.3389/fimmu.2017.00237] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
4 Mattheij MA, Schatorjé EJ, Gemen EF, van de Corput L, Nooijen PT, van der Burg M, de Vries E. A girl with autoimmune cytopenias, nonmalignant lymphadenopathy, and recurrent infections. Case Reports Immunol 2012;2012:196417. [PMID: 25379303 DOI: 10.1155/2012/196417] [Reference Citation Analysis]
5 Singer J, Testori C, Schellongowski P, Handisurya A, Müller C, Reitter EM, Graninger W, Knöbl P, Staudinger T, Winkler S, Thalhammer F. A case report of septic shock syndrome caused by S. pneumoniae in an immunocompromised patient despite of vaccination. BMC Infect Dis 2017;17:442. [PMID: 28641577 DOI: 10.1186/s12879-017-2481-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rudman Spergel A, Walkovich K, Price S, Niemela JE, Wright D, Fleisher TA, Rao VK. Autoimmune lymphoproliferative syndrome misdiagnosed as hemophagocytic lymphohistiocytosis. Pediatrics 2013;132:e1440-4. [PMID: 24101757 DOI: 10.1542/peds.2012-2748] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
7 Kaiser WJ, Upton JW, Mocarski ES. Viral modulation of programmed necrosis. Curr Opin Virol 2013;3:296-306. [PMID: 23773332 DOI: 10.1016/j.coviro.2013.05.019] [Cited by in Crossref: 102] [Cited by in F6Publishing: 89] [Article Influence: 11.3] [Reference Citation Analysis]
8 Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, Manno CS, Casper J, Grupp SA, Teachey DT. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood 2016;127:17-28. [PMID: 26504182 DOI: 10.1182/blood-2015-07-657981] [Cited by in Crossref: 100] [Cited by in F6Publishing: 93] [Article Influence: 14.3] [Reference Citation Analysis]
9 Vignesh P, Rawat A, Singh S. An Update on the Use of Immunomodulators in Primary Immunodeficiencies. Clin Rev Allergy Immunol 2017;52:287-303. [PMID: 27873163 DOI: 10.1007/s12016-016-8591-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
10 Patwardhan P, Landsteiner A, Lal LS, Geevarghese L, Le L, Nandal S, Cuker A. Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis. Ann Hematol 2021. [PMID: 34505942 DOI: 10.1007/s00277-021-04637-2] [Reference Citation Analysis]
11 Baleydier F, Bernard F, Ansari M. The Possibilities of Immunotherapy for Children with Primary Immunodeficiencies Associated with Cancers. Biomolecules 2020;10:E1112. [PMID: 32731356 DOI: 10.3390/biom10081112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Baker TS, Gambino KJ, Schriefer L, Lim JY, Steinberg KM, Fajgenbaum DC, Martín García-Sancho A, Byun M. A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease. Blood Adv 2018;2:2959-63. [PMID: 30404775 DOI: 10.1182/bloodadvances.2018023911] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
13 Walter JE, Farmer JR, Foldvari Z, Torgerson TR, Cooper MA. Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies. J Allergy Clin Immunol Pract 2016;4:1089-100. [PMID: 27836058 DOI: 10.1016/j.jaip.2016.08.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
14 Lindahl H, Bryceson YT. Neuroinflammation Associated With Inborn Errors of Immunity. Front Immunol 2022;12:827815. [DOI: 10.3389/fimmu.2021.827815] [Reference Citation Analysis]
15 Lehman HK. Autoimmunity and Immune Dysregulation in Primary Immune Deficiency Disorders. Curr Allergy Asthma Rep 2015;15:53. [PMID: 26233425 DOI: 10.1007/s11882-015-0553-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
16 Rispoli F, Valencic E, Girardelli M, Pin A, Tesser A, Piscianz E, Boz V, Faletra F, Severini GM, Taddio A, Tommasini A. Immunity and Genetics at the Revolving Doors of Diagnostics in Primary Immunodeficiencies. Diagnostics (Basel) 2021;11:532. [PMID: 33809703 DOI: 10.3390/diagnostics11030532] [Reference Citation Analysis]
17 Li P, Huang P, Yang Y, Hao M, Peng H, Li F. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS). Clin Rev Allergy Immunol 2016;50:55-63. [PMID: 25663566 DOI: 10.1007/s12016-015-8466-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
18 Rensing-Ehl A, Janda A, Lorenz MR, Gladstone BP, Fuchs I, Abinun M, Albert M, Butler K, Cant A, Cseh AM, Ebinger M, Goldacker S, Hambleton S, Hebart H, Houet L, Kentouche K, Kühnle I, Lehmberg K, Mejstrikova E, Niemeyer C, Minkov M, Neth O, Dückers G, Owens S, Rösler J, Schilling FH, Schuster V, Seidel MG, Smisek P, Sukova M, Svec P, Wiesel T, Gathmann B, Schwarz K, Vach W, Ehl S, Speckmann C. Sequential decisions on FAS sequencing guided by biomarkers in patients with lymphoproliferation and autoimmune cytopenia. Haematologica 2013;98:1948-55. [PMID: 23850805 DOI: 10.3324/haematol.2012.081901] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
19 Kaya Z, Işık M, Oruklu N, Kirkiz S, Bağrıaçık EÜ, Allende LM, Díaz-Madroñero MJ, Ruiz-García R, Pınarlı FG, Göçün Uyar P, Koçak Ü. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma. Turk J Haematol 2021;38:145-50. [PMID: 33375216 DOI: 10.4274/tjh.galenos.2020.2020.0618] [Reference Citation Analysis]
20 Gupta M, Aluri J, Desai M, Lokeshwar M, Taur P, Lenardo M, Bergerson J, Dalvi A, Mhatre S, Kulkarni M, Kambli P, Madkaikar M. Clinical, Immunological, and Molecular Findings in Four Cases of B Cell Expansion With NF-κB and T Cell Anergy Disease for the First Time From India. Front Immunol 2018;9:1049. [PMID: 29963038 DOI: 10.3389/fimmu.2018.01049] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
21 Kalfa TA. Warm antibody autoimmune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2016;2016:690-7. [PMID: 27913548 DOI: 10.1182/asheducation-2016.1.690] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 8.8] [Reference Citation Analysis]
22 Minemura H, Ikeda K, Tanino Y, Hashimoto Y, Nikaido T, Fukuhara A, Yokouchi H, Sato S, Tanino M, Oka T, Hebisawa A, Suzuki H, Ogawa K, Takeishi Y, Munakata M. Multicentric Castleman's disease with impaired lymphocytic apoptosis. Allergol Int 2015;64:112-4. [PMID: 25572569 DOI: 10.1016/j.alit.2014.08.009] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin North Am 2013;60:1489-511. [PMID: 24237984 DOI: 10.1016/j.pcl.2013.08.009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
24 Salzer E, Santos-Valente E, Klaver S, Ban SA, Emminger W, Prengemann NK, Garncarz W, Müllauer L, Kain R, Boztug H, Heitger A, Arbeiter K, Eitelberger F, Seidel MG, Holter W, Pollak A, Pickl WF, Förster-Waldl E, Boztug K. B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ. Blood 2013;121:3112-6. [PMID: 23319571 DOI: 10.1182/blood-2012-10-460741] [Cited by in Crossref: 92] [Cited by in F6Publishing: 72] [Article Influence: 10.2] [Reference Citation Analysis]
25 Gaefke CL, Metts J, Imanirad D, Nieves D, Terranova P, Dell'Orso G, Gambineri E, Miano M, Lockey RF, Walter JE, Westermann-Clark E. Case Report: A Novel Pathogenic Missense Mutation in FAS: A Multi-Generational Case Series of Autoimmune Lymphoproliferative Syndrome. Front Pediatr 2021;9:624116. [PMID: 33816397 DOI: 10.3389/fped.2021.624116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Price S, Shaw PA, Seitz A, Joshi G, Davis J, Niemela JE, Perkins K, Hornung RL, Folio L, Rosenberg PS, Puck JM, Hsu AP, Lo B, Pittaluga S, Jaffe ES, Fleisher TA, Rao VK, Lenardo MJ. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood 2014;123:1989-99. [PMID: 24398331 DOI: 10.1182/blood-2013-10-535393] [Cited by in Crossref: 133] [Cited by in F6Publishing: 104] [Article Influence: 16.6] [Reference Citation Analysis]
27 Xie Y, Pittaluga S, Price S, Raffeld M, Hahn J, Jaffe ES, Rao VK, Maric I. Bone marrow findings in autoimmune lymphoproliferative syndrome with germline FAS mutation. Haematologica 2017;102:364-72. [PMID: 27846610 DOI: 10.3324/haematol.2015.138081] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
28 Kuehn HS, Niemela JE, Rangel-Santos A, Zhang M, Pittaluga S, Stoddard JL, Hussey AA, Evbuomwan MO, Priel DA, Kuhns DB, Park CL, Fleisher TA, Uzel G, Oliveira JB. Loss-of-function of the protein kinase C δ (PKCδ) causes a B-cell lymphoproliferative syndrome in humans. Blood 2013;121:3117-25. [PMID: 23430113 DOI: 10.1182/blood-2012-12-469544] [Cited by in Crossref: 95] [Cited by in F6Publishing: 80] [Article Influence: 10.6] [Reference Citation Analysis]
29 Szczawińska-Popłonyk A, Grześk E, Schwartzmann E, Materna-Kiryluk A, Małdyk J. Case Report: Autoimmune Lymphoproliferative Syndrome vs. Chronic Active Epstein-Barr Virus Infection in Children: A Diagnostic Challenge. Front Pediatr 2021;9:798959. [PMID: 35036396 DOI: 10.3389/fped.2021.798959] [Reference Citation Analysis]
30 Erlacher M, Strahm B. Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in Childhood. Front Pediatr 2015;3:64. [PMID: 26217651 DOI: 10.3389/fped.2015.00064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
31 Thadchanamoorthy V, Dayasiri K. Dengue hemorrhagic fever as a rare cause of chronic immune thrombocytopenic purpura-a pediatric case report. Trop Med Health 2020;48:59. [PMID: 32699523 DOI: 10.1186/s41182-020-00248-1] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Oliveira JB. The expanding spectrum of the autoimmune lymphoproliferative syndromes. Curr Opin Pediatr 2013;25:722-9. [PMID: 24240292 DOI: 10.1097/MOP.0000000000000032] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
33 Sharma S, Hussain MS, Agarwal N, Bhurani D, Khan MA, Ahmad Ansari MA. Efficacy of sirolimus for treatment of autoimmune lymphoproliferative syndrome: a systematic review of open label clinical studies. Expert Opinion on Orphan Drugs 2021;9:219-26. [DOI: 10.1080/21678707.2021.1970523] [Reference Citation Analysis]
34 Madhivanan K, Ramadesikan S, Hsieh WC, Aguilar MC, Hanna CB, Bacallao RL, Aguilar RC. Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins. Hum Mol Genet 2020;29:1700-15. [PMID: 32391547 DOI: 10.1093/hmg/ddaa086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kistangari G, McCrae KR. Immune thrombocytopenia. Hematol Oncol Clin North Am 2013;27:495-520. [PMID: 23714309 DOI: 10.1016/j.hoc.2013.03.001] [Cited by in Crossref: 83] [Cited by in F6Publishing: 59] [Article Influence: 9.2] [Reference Citation Analysis]
36 Bride K, Teachey D. Autoimmune lymphoproliferative syndrome: more than a FAScinating disease. F1000Res 2017;6:1928. [PMID: 29123652 DOI: 10.12688/f1000research.11545.1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]